---
---

# 21 U.S.C., USLM ref /us/usc/t21/s360bbb–6

* Portions Copyright © 2016 the authors of the https://github.com/publicdocs project.
  Use of this file is subject to the NOTICE at [https://github.com/publicdocs/uscode/blob/master/NOTICE](https://github.com/publicdocs/uscode/blob/master/NOTICE)
* See the [Document Metadata](././../../../../../..//README.md) for more information.
  This file is generated from historical government data; content and/or formatting may be inaccurate and out-of-date and should not be used for official purposes.

----------
----------

[Previous](./../../../../../..//us/usc/t21/ch9/schV/ptE/m__us_usc_t21_s360bbb–5.md) | [Next](./../../../../../..//us/usc/t21/ch9/schV/ptE/m__us_usc_t21_s360bbb–7.md) | [Root of Title](./../../../../../../) | [Other Versions of this Document](https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft21%2Fs360bbb%E2%80%936)

## § 360bbb–6. Risk communication

    (a) __Advisory Committee on Risk Communication__ 

        (1) __In general__ 

            The Secretary shall establish an advisory committee to be known as the “Advisory Committee on Risk Communication” (referred to in this section as the “Committee”).

        (2) __Duties of Committee__ 

            The Committee shall advise the Commissioner on methods to effectively communicate risks associated with the products regulated by the Food and Drug Administration.

        (3) __Members__ 

            The Secretary shall ensure that the Committee is composed of experts on risk communication, experts on the risks described in subsection (b), and representatives of patient, consumer, and health professional organizations.

        (4) __Permanence of Committee__ 

            Section 14 of the Federal Advisory Committee Act shall not apply to the Committee established under this subsection.

    (b) __Partnerships for risk communication__ 

        (1) __In general__ 

            The Secretary shall partner with professional medical societies, medical schools, academic medical centers, and other stakeholders to develop robust and multi-faceted systems for communication to health care providers about emerging postmarket drug risks.

        (2) __Partnerships__ 

        The systems developed under paragraph (1) shall—

            (A) account for the diversity among physicians in terms of practice, willingness to adopt technology, and medical specialty; and

            (B) include the use of existing communication channels, including electronic communications, in place at the Food and Drug Administration.

([June 25, 1938, ch. 675, § 567][/us/act/1938-06-25/ch675/s567], as added [Pub. L. 110–85, title IX, § 917][/us/pl/110/85/s917], Sept. 27, 2007, [121 Stat. 960][/us/stat/121/960].)

 __References in Text__ 

    Section 14 of the Federal Advisory Committee Act, referred to in subsec. (a)(4), is [section 14 of Pub. L. 92–463][/us/pl/92/463/s14], which is set out in the Appendix to Title 5, Government Organization and Employees.

----------

[Previous](./../../../../../..//us/usc/t21/ch9/schV/ptE/m__us_usc_t21_s360bbb–5.md) | [Next](./../../../../../..//us/usc/t21/ch9/schV/ptE/m__us_usc_t21_s360bbb–7.md) | [Root of Title](./../../../../../../) | [Other Versions of this Document](https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft21%2Fs360bbb%E2%80%936)

----------
----------

[/us/act/1938-06-25/ch675/s567]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fact%2F1938-06-25%2Fch675%2Fs567
[/us/pl/110/85/s917]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F110%2F85%2Fs917
[/us/stat/121/960]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fstat%2F121%2F960
[/us/pl/92/463/s14]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F92%2F463%2Fs14


